You’ve viewed 1 of 5 articles this month. If you wish to read unlimited content, please log in or register below. Registration is free.

In a Q&A with Jeff Casberg, MS, RPh, senior vice president of clinical pharmacy services at IPD Analytics, Casberg explains ...

Strength - A very broad, exciting drug development pipeline with some real contenders already in the mix IDYA is mostly an early-phase developmental biotech, with the notable exception of ...

A surge of generics, biosimilars, and innovative therapies is expected in 2025, addressing conditions from cancer to chronic ...

During a recent panel discussion sponsored by Purdue University, industry leaders explain how the technology is revolutionizing drug development and production ...

The drugmaker said one patient became ill after being treated with its experimental weight-loss drug, danuglipron.

suggesting the market does not ascribe any value to their existing business or drug development pipeline, according to Jefferies analysts. "The sector needs a predictable, science-led regulator to ...

Recursion Pharmaceuticals' stock is soaring today on news the FDA is planning on phasing out some animal testing, replacing ...

Pfizer will halt its development of a weight-loss drug that was being closely watched by investors, in a significant blow to the US pharmaceutical group. The company said on Monday that it would stop ...

The U.S. Food and Drug Administration is replacing animal testing with human-relevant methods, including artificial ...

suggesting the market does not ascribe any value to their existing business or drug development pipeline, according to Jefferies analysts. "The sector needs a predictable, science-led regulator to ...